Literature DB >> 9327455

Perfusion cells for studying regional variation in oral-mucosal permeability in humans. I: Kinetic aspects in oral-mucosal absorption of alkylparabens.

Y Kurosaki1, K Yano, T Kimura.   

Abstract

PURPOSE: To evaluate regional differences in permeability of human oral mucosa.
METHODS: Newly designed perfusion cells were used for the investigation. The cells were applied to 5 different sites, i.e., dorsum of tongue, ventral surface of tongue, labial mucosa, floor of mouth and buccal mucosa of human volunteers. Model drugs used were methyl-, ethyl-, propyl- and butylparaben, which are passively absorbed from oral mucosa and have different lipophilicities. Biexponential disappearance profiles of the alkylparabens were analyzed kinetically using a two-compartment linear open model.
RESULTS: Both the partitioning parameters to the oral mucosa and the absorption rate constants to the blood circulation correlated to the lipophilicities of the compounds in all mucosa. As to the former parameter, no significant difference was recognized in all mucosa. While, the latter parameter exhibited the regional difference; the absorption rate constants in buccal mucosa were approximately one-half of those estimated in other oral mucosa. A positive relation was recognized between the retention in oral-mucosal compartment and the drug lipophilicity.
CONCLUSIONS: The newly designed perfusion cells used in this study were useful to examine the regional variations of drug absorption from oral mucosa in humans. The absorption rate constant, the partition to oral mucosa and the residence time in oral mucosa increased with lipophilicity of the compound. The regional difference in the drug absorption process was demonstrated; the slow absorption and the prolonged retention were demonstrated in buccal mucosa.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327455     DOI: 10.1023/a:1012171227272

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  A membrane model of the human oral mucosa as derived from buccal absorption performance and physicochemical properties of the beta-blocking drugs atenolol and propranolol.

Authors:  W Schürmann; P Turner
Journal:  J Pharm Pharmacol       Date:  1978-03       Impact factor: 3.765

2.  Novel method for determination of partition coefficients of penicillins and cephalosporins by high-pressure liquid chromatography.

Authors:  T Yamana; A Tsuji; E Miyamoto; O Kubo
Journal:  J Pharm Sci       Date:  1977-05       Impact factor: 3.534

3.  Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes.

Authors:  A H Beckett; E J Triggs
Journal:  J Pharm Pharmacol       Date:  1967-12       Impact factor: 3.765

4.  Drug absorption. 3. Effect of membrane storage on the kinetics of drug absorption.

Authors:  J T Doluisio; W G Crouthamel; G H Tan; J V Swintosky; L W Dittert
Journal:  J Pharm Sci       Date:  1970-01       Impact factor: 3.534

5.  Buccal and oral bioavailability of nalbuphine in rats.

Authors:  M A Hussain; B J Aungst; E Shefter
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534

6.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

7.  Studies on drug absorption from oral cavity. II. Influence of the unstirred water layer on absorption from hamster cheek pouch in vitro and in vivo.

Authors:  Y Kurosaki; S Hisaichi; C Hamada; T Nakayama; T Kimura
Journal:  J Pharmacobiodyn       Date:  1987-04

8.  Human buccal absorption of flurbiprofen.

Authors:  C L Barsuhn; L S Olanoff; D D Gleason; E L Adkins; N F Ho
Journal:  Clin Pharmacol Ther       Date:  1988-08       Impact factor: 6.875

9.  Buccal morphine--a new route for analgesia?

Authors:  M D Bell; G R Murray; P Mishra; T N Calvey; B D Weldon; N E Williams
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

10.  Application of propranolol to the keratinized oral mucosa: avoidance of first-pass elimination and the use of 1-dodecylazacycloheptan-2-one (Azone) as an absorption enhancer of bioadhesive film-dosage form.

Authors:  Y Kurosaki; T Takatori; M Kitayama; T Nakayama; T Kimura
Journal:  J Pharmacobiodyn       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.